Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07645378
What this trial is testing

Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa

Who this might be right for
HIV (Human Immunodeficiency Virus)HPVCervical Precancer+1 more
Fred Hutchinson Cancer Center 200
Large-scale testing (Phase 3)Study completedNCT01900106
What this trial is testing

A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)

Who this might be right for
HIV Infection
University of Modena and Reggio Emilia 47
Not applicableStudy completedNCT06368453
What this trial is testing

Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test

Who this might be right for
Human Immunodeficiency Virus I InfectionHuman Immunodeficiency Virus II Infection
bioLytical Laboratories 1,728
Post-approval studies (Phase 4)Ended earlyNCT01591902
What this trial is testing

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

Who this might be right for
Diabetic RetinopathyHIV
Theratechnologies 129
Large-scale testing (Phase 3)Study completedNCT01386294
What this trial is testing

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

Who this might be right for
HIV Prevention
CONRAD 2,059
Not applicableLooking for participantsNCT06554223
What this trial is testing

The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care

Who this might be right for
Human Immunodeficiency Virus
Brigham and Women's Hospital 310
Testing effectiveness (Phase 2)Study completedNCT02099994
What this trial is testing

Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults

Who this might be right for
AIDS
University of Oxford 72
Early research (Phase 1)Study completedNCT00000986
What this trial is testing

The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT02935686
What this trial is testing

A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 155
Large-scale testing (Phase 3)Study completedNCT00421551
What this trial is testing

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 225
Not applicableStudy completedNCT00002029
What this trial is testing

Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent

Who this might be right for
HIV Infections
Abbott
Early research (Phase 1)Study completedNCT02059031
What this trial is testing

Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 24
Early research (Phase 1)Study completedNCT00000739
What this trial is testing

Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Not applicableStudy completedNCT00000719
What this trial is testing

A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Post-approval studies (Phase 4)Study completedNCT01866267
What this trial is testing

Switching Undetectables to Selzentry

Who this might be right for
Human Immunodeficiency VirusAIDS
St. Hope Foundation 31
Testing effectiveness (Phase 2)Study completedNCT00001114
What this trial is testing

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Testing effectiveness (Phase 2)Study completedNCT00196586
What this trial is testing

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Who this might be right for
HIV InfectionsChronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 75
Testing effectiveness (Phase 2)Ended earlyNCT01026727
What this trial is testing

Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy

Who this might be right for
HIV Infections
Myrexis Inc. 2
Early research (Phase 1)Study completedNCT03575962
What this trial is testing

Compare the Relative Bioavailability of Two Different Formulations of GSK3640254

Who this might be right for
HIV Infections
ViiV Healthcare 14
Testing effectiveness (Phase 2)Study completedNCT01146119
What this trial is testing

Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)

Who this might be right for
Influenza
BiondVax Pharmaceuticals ltd. 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation